We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The European Union wants to expand ongoing trade talks between the U.S. and EU to address regulatory harmonization on drug approval requirements, guidelines and GMP compliance. Read More
Fifteen House Democrats are calling on top U.S. trade officials to clarify the administration’s position on compulsory licensing for Novartis’ cancer drug Gleevec in Colombia. Read More